Skip to content

A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial of Fecal Microbiota Transplantation for Autism Spectrum Disorder

A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial of Fecal Microbiota Transplantation for Autism Spectrum Disorder

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100043906
Enrollment
Unknown
Registered
2021-03-05
Start date
2021-03-29
Completion date
Unknown
Last updated
2021-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism spectrum disorder

Interventions

treatment group:Fecal microbiota capsule

Sponsors

Department of Colorectal Disease, the Tenth People's Hospital, Tongji University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 10 Years

Inclusion criteria

Inclusion criteria: (1) Age 3-13 years old, male or female; (2) Meeting the ASD diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) of the American Psychiatric Association; (3) Accompanied with diarrhea, constipation, abdominal distension and/or food allergy/intolerance for at least 6 months and above symptoms occurred in the last 3 months; (4) Subjects and/or guardians sign the informed consent, and agree that the researcher will cooperate with the whole process of the clinical trial and collect clinical data, blood, saliva, urine and feces samples; (5) Able to swallow 3# FMT capsules by themselves.

Exclusion criteria

Exclusion criteria: (1) Diagnosis of Rett syndrome. (2) Previous history of brain injury, cerebral palsy, encephalitis or other brain organic diseases; (3) Diagnosis of other mental diseases; (4) Diagnosis of intestinal organic diseases, such as congenital megacolon, intestinal obstruction, intussusception, inflammatory bowel disease and etc. (5) Severe obesity or malnutrition; (6) Using probiotics, antibiotics and other drugs affecting intestinal flora in a planned way within the last 3 months or in the following 6 months; (7) Having received FMT treatment in the past 12 months.

Design outcomes

Primary

MeasureTime frame
Diversity and richness of flora;

Secondary

MeasureTime frame
Childhood Autism Rating Scale;Autism Behavior Checklist;Bristol Stool Form Scale;Gastrointestinal Symptom Rating Scale;Social Anxiety Scale for Children;Metabolic profile;

Countries

China

Contacts

Public ContactQin Huanlong

Department of Colorectal Disease, Shanghai Tenth People's Hospital

qin_huanlong@126.com+86 15896453859

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 13, 2026